Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Baxter International Inc. (BAX)

52.35   0.84 (1.63%) 12-07 16:00
Open: 51.48 Pre. Close: 51.51
High: 52.76 Low: 51.33
Volume: 4,450,286 Market Cap: 26,391(M)

Technical analysis

as of: 2022-12-07 4:20:35 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 63.31     One year: 66.47
Support: Support1: 49.83    Support2: 41.45
Resistance: Resistance1: 54.2    Resistance2: 56.9
Pivot: 54.36
Moving Average: MA(5): 52.15     MA(20): 54.18
MA(100): 57.05     MA(250): 69.33
MACD: MACD(12,26): -0.6     Signal(9): -0.3
Stochastic oscillator: %K(14,3): 12.6     %D(3): 12.4
RSI: RSI(14): 43.7
52-week: High: 89.69  Low: 49.83
Average Vol(K): 3-Month: 4,092 (K)  10-Days: 4,761 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ BAX ] has closed above bottom band by 20.5%. Bollinger Bands are 3.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 52.83 - 53.04 53.04 - 53.25
Low: 50.8 - 51.04 51.04 - 51.26
Close: 51.98 - 52.35 52.35 - 52.71

Company Description

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Headline News

Sat, 03 Dec 2022
Should You Buy BABB (BAX) Saturday? - InvestorsObserver

Fri, 02 Dec 2022
Changes benefit Bax Townsend in Lubbock Christian football's run to state -

Fri, 02 Dec 2022
OSS Titles To Bax, MacDonald - Standardbred Canada

Fri, 02 Dec 2022
Is Baxter International Inc (BAX) Stock Worth a Buy Friday? - InvestorsObserver

Fri, 02 Dec 2022
BAX Announces 2023 Emerge NYC Applications Open - Broadway World

Thu, 01 Dec 2022
Interesting BAX Put And Call Options For January 2023 - Nasdaq

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Medical Instruments & Supplies
Shares Out. 504 (M)
Shares Float 503 (M)
% Held by Insiders 0.2 (%)
% Held by Institutions 89.4 (%)
Shares Short 6,630 (K)
Shares Short P.Month 5,680 (K)

Stock Financials

EPS Est Next Qtl 0.62
EPS Est This Year 2.41
EPS Est Next Year 2.7
Book Value (p.s.) 10.97
Profit Margin (%) -16.2
Operating Margin (%) 11.1
Return on Assets (ttm) 4.3
Return on Equity (ttm) -32.9
Qtrly Rev. Growth 17
Gross Profit (p.s.) 10.41
Sales Per Share 29.23
EBITDA (p.s.) 5.87
Qtrly Earnings Growth 0
Operating Cash Flow 1,460 (M)
Levered Free Cash Flow 769 (M)

Stock Valuations

PE Ratio 26.18
PEG Ratio 2.7
Price to Book value 4.76
Price to Sales 1.79
Price to Cash Flow 18.07

Stock Dividends

Dividend 0.28
Forward Dividend 0
Dividend Yield 0.5%
Dividend Pay Date 2022-01-02
Ex-Dividend Date 2021-12-01
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.